Jennison Associates’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-69,618
| Closed | -$6.67M | – | 586 |
|
|
2023
Q2 | $6.67M | Buy |
69,618
+36,381
| +109% | +$3.49M | 0.01% | 405 |
|
|
2023
Q1 | $3.77M | Sell |
33,237
-185
| -0.6% | -$21K | ﹤0.01% | 448 |
|
|
2022
Q4 | $3.74M | Buy |
+33,422
| New | +$3.74M | ﹤0.01% | 436 |
|
|
2018
Q2 | – | Sell |
-10,510
| Closed | -$1.54M | – | 683 |
|
|
2018
Q1 | $1.54M | Sell |
10,510
-869
| -8% | -$128K | ﹤0.01% | 534 |
|
|
2017
Q4 | $2.31M | Buy |
+11,379
| New | +$2.31M | ﹤0.01% | 519 |
|
|
2016
Q3 | – | Sell |
-33,532
| Closed | -$19.5M | – | 667 |
|
|
2016
Q2 | $19.5M | Buy |
33,532
+13,469
| +67% | +$7.83M | 0.02% | 402 |
|
|
2016
Q1 | $10.7M | Buy |
20,063
+115
| +0.6% | +$61.1K | 0.01% | 449 |
|
|
2015
Q4 | $14M | Buy |
19,948
+363
| +2% | +$255K | 0.01% | 453 |
|
|
2015
Q3 | $11.6M | Buy |
19,585
+85
| +0.4% | +$50.4K | 0.01% | 490 |
|
|
2015
Q2 | $16.2M | Buy |
+19,500
| New | +$16.2M | 0.01% | 470 |
|